- In the past year, United States Antimony Corporation secured a US$27.0 million defense contract and reported a mining breakthrough, yet its financial results showed widening losses and repeated earnings misses.
- This contrast between promising operational announcements and weakening performance has raised questions about how effectively the company can translate opportunities into sustainable financial progress.
- We’ll now examine how this mix of new contracts and deteriorating results could reshape United States Antimony’s investment narrative.
Find 43 companies with promising cash flow potential yet trading below their fair value.
United States Antimony Investment Narrative Recap
To own United States Antimony today, you have to believe its role in US critical minerals and defense supply chains can eventually outweigh ongoing losses and balance sheet strain. The latest earnings misses and widening losses cut against that thesis in the near term, while contract wins and processing expansion still underpin the main catalyst: proving that higher volumes and defense demand can move the company toward sustainable profitability. For now, the core risk remains execution and cash burn, and the new information does not materially change that.
In that context, the US$27.0 million defense contract stands out. It directly ties into the company’s positioning as a domestic supplier of antimony for military and industrial uses, which was central to more optimistic expectations about throughput growth and future margins. But the recent financial results highlight how much work is still required before such contracts translate into stable earnings, making this announcement more a test of execution than a clear turning point.
Yet despite these contracts, investors should be aware that...
Read the full narrative on United States Antimony (it's free!)
United States Antimony's narrative projects $343.6 million revenue and $83.0 million earnings by 2029. This requires 106.5% yearly revenue growth and a $99.2 million earnings increase from -$16.2 million today.
Uncover how United States Antimony's forecasts yield a $13.06 fair value, a 90% upside to its current price.
Exploring Other Perspectives
Before this latest setback, the most optimistic analysts were assuming revenue could reach about US$333 million and earnings about US$71 million, so if you believed that story of rapid growth and strong defense led demand, this new evidence of losses and contract concentration risk may prompt you to reconsider how confident you really are in those assumptions.
Explore 17 other fair value estimates on United States Antimony - why the stock might be worth less than half the current price!
Decide For Yourself
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your United States Antimony research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
- Our free United States Antimony research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate United States Antimony's overall financial health at a glance.
Want Some Alternatives?
Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:
- Capitalize on the AI infrastructure supercycle with our selection of the 50 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
- Uncover the next big thing with 22 elite penny stocks that balance risk and reward.
- AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com